Search

Your search keyword '"Entz-Werle N"' showing total 167 results

Search Constraints

Start Over You searched for: Author "Entz-Werle N" Remove constraint Author: "Entz-Werle N"
167 results on '"Entz-Werle N"'

Search Results

1. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

2. Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆

4. 1506P Role of 18F-FDG PET/CT in the initial staging of very high risk Ewing sarcoma in a prospective multicentric phase II study: Is there still a place for bone marrow sampling?

5. 468P Real-world safety of trametinib monotherapy or in combination with dabrafenib in children, adolescents, and young adults with relapsed or refractory low-grade glioma (LGG) and high-grade glioma (HGG)

8. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort

9. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study

15. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

18. Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

20. Phase I combination dose-finding/phase II expansion cohorts of lenvatinib + etoposide + ifosfamide in patients (pts) aged 2 to ≤ 25 years with relapsed/refractory (r/r) osteosarcoma

23. Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease

24. Cabozantinib in patients with advanced osteosarcomas and Ewing sarcomas: A French Sarcoma Group (FSG)/ US National Cancer Institute phase II collaborative study

25. Diagnosis of Constitutional Mismatch Repair-deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents

26. 1676PD - Phase I combination dose-finding/phase II expansion cohorts of lenvatinib + etoposide + ifosfamide in patients (pts) aged 2 to ≤ 25 years with relapsed/refractory (r/r) osteosarcoma

29. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

30. Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high grade glioma

33. BT-05 * FUNCTIONAL DIVERSITY AND CO-OPERATIVITY OF SUBCLONAL POPULATIONS OF PAEDIATRIC GLIOBLASTOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA CELLS

34. TUMOUR BIOLOGY

35. CLINICAL TRIALS

36. HIGH GRADE GLIOMAS AND DIPG

37. SFCE CO-09 - Syndrome CMMR-D : description clinique dans une série française

39. Lopinavir/Ritonavir Monotherapy as a Nucleoside Analogue–Sparing Strategy to Prevent HIV-1 Mother-to-Child Transmission: The ANRS 135 PRIMEVA Phase 2/3 Randomized Trial

40. Pancréatites aiguës sévères à l'asparaginase chez l'enfant: étude rétrospective multicentrique.

42. BIOLOGY

46. Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping

Catalog

Books, media, physical & digital resources